Drug Shortage Report for TEVA-SPIRONOLACTONE

Last updated on 2021-02-25 History
Report ID 134749
Drug Identification Number 00613215
Brand name TEVA-SPIRONOLACTONE
Common or Proper name SPIRONOLACTONE 25MG TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SPIRONOLACTONE
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size U/D 100's
ATC code C03DA
ATC description POTASSIUM-SPARING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-23
Estimated end date 2021-04-30
Actual end date
Shortage status Actual shortage
Updated date 2021-02-25
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-02-25 French Compare
v1 2021-02-25 English Compare